Clinical Evaluation of Percent Free Prostate–Specific Antigen Using the AxSYM System in the Best Analytical Scenario

M. Gion,R. Mione,P. Barioli,M. Barichello,Filiberto Zattoni,Tommaso Prayer-Galetti,Mario Plebani,Giuseppe Aimo,Carlo Terrone,Manferrari F,Madeddu G,Livio Caberlotto,A. Fandella,C. Pianon,Vianello L,B. Amoroso

Clinical Evaluation of Percent Free Prostate–Specific Antigen Using the AxSYM System in the Best Analytical Scenario

2000

M. Gion
R. Mione
P. Barioli
M. Barichello
Filiberto Zattoni
Tommaso Prayer-Galetti
Mario Plebani
Giuseppe Aimo
Carlo Terrone
Manferrari F
Madeddu G
Livio Caberlotto
A. Fandella
C. Pianon
Vianello L
B. Amoroso

Objective: Percent free prostate–specific antigen (PSA) is a promising tool for prostate cancer (CaP) diagnosis. However, its diagnostic performances have not yet been established.

Keywords:

Prostate-specific antigen
Percent Free Prostate-Specific Antigen
Urology
Adenoma
Prostate cancer
Pathology
Cancer
Prostate
Antigen
Differential diagnosis
Medicine
diagnosis differential
clinical evaluation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations